JP2015147764A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015147764A5 JP2015147764A5 JP2015011332A JP2015011332A JP2015147764A5 JP 2015147764 A5 JP2015147764 A5 JP 2015147764A5 JP 2015011332 A JP2015011332 A JP 2015011332A JP 2015011332 A JP2015011332 A JP 2015011332A JP 2015147764 A5 JP2015147764 A5 JP 2015147764A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- less
- mmhg
- leu
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461931071P | 2014-01-24 | 2014-01-24 | |
| US61/931,071 | 2014-01-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015147764A JP2015147764A (ja) | 2015-08-20 |
| JP2015147764A5 true JP2015147764A5 (OSRAM) | 2018-03-01 |
| JP6624787B2 JP6624787B2 (ja) | 2019-12-25 |
Family
ID=52630418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015011332A Expired - Fee Related JP6624787B2 (ja) | 2014-01-24 | 2015-01-23 | 脳内出血を治療するための組成物および方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20160375109A1 (OSRAM) |
| EP (1) | EP3096779B1 (OSRAM) |
| JP (1) | JP6624787B2 (OSRAM) |
| KR (3) | KR20160093731A (OSRAM) |
| CN (2) | CN105934250A (OSRAM) |
| AU (1) | AU2015208819B2 (OSRAM) |
| BR (1) | BR112016014617A2 (OSRAM) |
| CA (1) | CA2937418A1 (OSRAM) |
| DK (1) | DK3096779T3 (OSRAM) |
| ES (1) | ES2772802T3 (OSRAM) |
| HU (1) | HUE047588T4 (OSRAM) |
| IL (1) | IL246637A0 (OSRAM) |
| MX (1) | MX375355B (OSRAM) |
| PL (1) | PL3096779T3 (OSRAM) |
| PT (1) | PT3096779T (OSRAM) |
| RU (1) | RU2016126423A (OSRAM) |
| SI (1) | SI3096779T1 (OSRAM) |
| WO (1) | WO2015110939A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150103205A (ko) | 2013-01-31 | 2015-09-09 | 화이자 인코포레이티드 | 인자 Xa 억제를 길항하기 위한 조성물 및 방법 |
| SG11201601221XA (en) | 2013-09-24 | 2016-04-28 | Pfizer | Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2570330A1 (en) * | 2004-06-21 | 2005-12-29 | Novo Nordisk Health Care A/S | Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) |
| MX336958B (es) * | 2005-11-15 | 2016-02-05 | Philadelphia Children Hospital | Metodos y composiciones para modular la hemostasia. |
| CN101918025A (zh) * | 2008-01-18 | 2010-12-15 | 诺沃-诺迪斯克保健股份有限公司 | 因子Ⅶa或因子Ⅶa等同物用于防止或减弱选择的脑内出血患者亚群在脑内出血(ICH)后出血增多和/或水肿形成的用途 |
| JP6163304B2 (ja) * | 2009-07-15 | 2017-07-12 | ポートラ ファーマシューティカルズ， インコーポレイテッド | 第Ｘａ因子インヒビターの解毒剤の単位用量処方物およびその使用方法 |
| WO2011020866A2 (en) * | 2009-08-20 | 2011-02-24 | Csl Behring Gmbh | Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| US9371522B2 (en) * | 2011-09-30 | 2016-06-21 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating hemostasis |
| SG11201500579SA (en) * | 2012-07-25 | 2015-02-27 | Catalyst Biosciences Inc | Modified factor x polypeptides and uses thereof |
| KR20150103205A (ko) * | 2013-01-31 | 2015-09-09 | 화이자 인코포레이티드 | 인자 Xa 억제를 길항하기 위한 조성물 및 방법 |
-
2015
- 2015-01-15 CA CA2937418A patent/CA2937418A1/en not_active Abandoned
- 2015-01-15 CN CN201580005696.XA patent/CN105934250A/zh active Pending
- 2015-01-15 SI SI201531081T patent/SI3096779T1/sl unknown
- 2015-01-15 HU HUE15708578A patent/HUE047588T4/hu unknown
- 2015-01-15 KR KR1020167019778A patent/KR20160093731A/ko not_active Ceased
- 2015-01-15 KR KR1020217001254A patent/KR20210008177A/ko not_active Ceased
- 2015-01-15 CN CN202011260045.4A patent/CN112156176A/zh active Pending
- 2015-01-15 ES ES15708578T patent/ES2772802T3/es active Active
- 2015-01-15 DK DK15708578.8T patent/DK3096779T3/da active
- 2015-01-15 KR KR1020187002632A patent/KR20180014221A/ko not_active Ceased
- 2015-01-15 AU AU2015208819A patent/AU2015208819B2/en not_active Ceased
- 2015-01-15 EP EP15708578.8A patent/EP3096779B1/en not_active Not-in-force
- 2015-01-15 BR BR112016014617A patent/BR112016014617A2/pt not_active IP Right Cessation
- 2015-01-15 US US15/112,088 patent/US20160375109A1/en not_active Abandoned
- 2015-01-15 PL PL15708578T patent/PL3096779T3/pl unknown
- 2015-01-15 PT PT157085788T patent/PT3096779T/pt unknown
- 2015-01-15 MX MX2016009665A patent/MX375355B/es active IP Right Grant
- 2015-01-15 WO PCT/IB2015/050313 patent/WO2015110939A1/en not_active Ceased
- 2015-01-15 RU RU2016126423A patent/RU2016126423A/ru not_active Application Discontinuation
- 2015-01-23 JP JP2015011332A patent/JP6624787B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-06 IL IL246637A patent/IL246637A0/en unknown
-
2018
- 2018-10-11 US US16/157,194 patent/US20190231856A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shechter et al. | Harnessing monocyte‐derived macrophages to control central nervous system pathologies: no longer ‘if’but ‘how’ | |
| US9162975B2 (en) | Phenyl carbamate compounds for use in alleviating or treating pain | |
| RU2707191C2 (ru) | Нейродегенеративные расстройства | |
| Akyuz et al. | Effect of early bilateral decompressive craniectomy on outcome for severe traumatic brain injury. | |
| JP2010532761A5 (OSRAM) | ||
| NZ600544A (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
| JP2022511568A5 (OSRAM) | ||
| JP2008521796A5 (OSRAM) | ||
| CN111201029B (zh) | Zag来源肽及其用途 | |
| BR112022009898A2 (pt) | Composições e métodos para desrepressão de genes alvo do fator de transcrição silenciador de re1 | |
| Zhang et al. | (R, S)-ketamine promotes striatal neurogenesis and sensorimotor recovery through improving poststroke depression–mediated decrease in atrial natriuretic peptide | |
| Xu et al. | Beneficial effects of local profound hypothermia and the possible mechanism after experimental spinal cord injury in rats | |
| Tang et al. | TREM2 alleviates long-term cognitive dysfunction after subarachnoid hemorrhage in mice by attenuating hippocampal neuroinflammation via PI3K/Akt signaling pathway | |
| Soni et al. | Exploring therapeutic potential: Targeting TRPM7 in neurodegenerative diseases | |
| WO2023011609A1 (zh) | 氨基噻唑衍生物在制备免疫性炎症药物中的用途 | |
| TWI496579B (zh) | 類鋅手指胜肽、其表現質體、及包含其之醫藥組成物之用途 | |
| Bellani et al. | Diffusion imaging studies of white matter integrity in bipolar disorder | |
| RU2016126423A (ru) | Композиции и способы лечения внутримозгового кровоизлияния | |
| US20170252403A1 (en) | Methods and compositions for treating retinal disorders | |
| US20080045611A1 (en) | Methods for the therapeutic use of a carbonic anhydrase inhibitor for reducing spinal cord edema | |
| RU2013139704A (ru) | Применение белка yb-1 и его фрагментов для изготовления лекарственных средств при лечении болезни альцгеймера | |
| Czlonkowska | THE CLINICAL DEVELOPMENT OF CEREBROLYSIN: NEW APPROACHES IN STROKE STUDIES. A COMMENTARY TO THE CARS STUDY | |
| Dovgiy et al. | Rehabilitation of patients suffering from ischemic stroke by methods of ozonotherapy, kinesitherapy, physiotherapy and acupuncture | |
| Shim et al. | A Clinical Report of Wallenberg's Syndrome | |
| CN103788179B (zh) | 多肽小分子及其在制备防治膀胱过度活跃药物中的应用 |